Literature DB >> 7615771

Distribution of both rotavirus VP4 genotypes and VP7 serotypes among hospitalized and nonhospitalized Israeli children.

I Silberstein1, L M Shulman, E Mendelson, I Shif.   

Abstract

Human rotaviruses belonging to genotype P9, of probable feline origin, which included both G3 and G1 serotypes, were detected in 3.8% of children shedding rotaviruses who attended sick fund clinics throughout Israel. None were detected in children admitted to hospitals because of severe diarrhea. In contrast, the relative prevalences of genotypes P8 and P4 were similar between the two groups.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7615771      PMCID: PMC228184          DOI: 10.1128/jcm.33.5.1421-1422.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  Human rotavirus strain with unique VP4 neutralization epitopes as a result of natural reassortment between members of the AU-1 and Wa genogroups.

Authors:  O Nakagomi; E Kaga; T Nakagomi
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  A novel group A rotavirus G serotype: serological and genomic characterization of equine isolate FI23.

Authors:  G F Browning; T A Fitzgerald; R M Chalmers; D R Snodgrass
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

Review 3.  Rotavirus gene structure and function.

Authors:  M K Estes; J Cohen
Journal:  Microbiol Rev       Date:  1989-12

Review 4.  Rotaviruses: a review.

Authors:  M K Estes; E L Palmer; J F Obijeski
Journal:  Curr Top Microbiol Immunol       Date:  1983       Impact factor: 4.291

5.  Antigenic relationships among human rotaviruses as determined by outer capsid protein VP4.

Authors:  M Gorziglia; G Larralde; A Z Kapikian; R M Chanock
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

6.  Isolation and characterization of two distinct human rotavirus strains with G6 specificity.

Authors:  G Gerna; A Sarasini; M Parea; S Arista; P Miranda; H Brüssow; Y Hoshino; J Flores
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

7.  A VP4 sequence highly conserved in human rotavirus strain AU-1 and feline rotavirus strain FRV-1.

Authors:  Y Isegawa; O Nakagomi; T Nakagomi; S Ueda
Journal:  J Gen Virol       Date:  1992-08       Impact factor: 3.891

8.  Identification of group A rotavirus gene 4 types by polymerase chain reaction.

Authors:  J R Gentsch; R I Glass; P Woods; V Gouvea; M Gorziglia; J Flores; B K Das; M K Bhan
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

9.  Serological and genomic characterization of L338, a novel equine group A rotavirus G serotype.

Authors:  G F Browning; R M Chalmers; T A Fitzgerald; D R Snodgrass
Journal:  J Gen Virol       Date:  1991-05       Impact factor: 3.891

10.  Survey of rotavirus G and P types associated with human gastroenteritis in São Paulo, Brazil, from 1986 to 1992.

Authors:  M do C Timenetsky; N Santos; V Gouvea
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

View more
  16 in total

1.  Rotavirus strains bearing genotype G9 or P[9] recovered from Brazilian children with diarrhea from 1997 to 1999.

Authors:  N Santos; E M Volotão; C C Soares; M C Albuquerque; F M da Silva; T R de Carvalho; C F Pereira; V Chizhikov; Y Hoshino
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

2.  Evidence of high-frequency genomic reassortment of group A rotavirus strains in Bangladesh: emergence of type G9 in 1995.

Authors:  L E Unicomb; G Podder; J R Gentsch; P A Woods; K Z Hasan; A S Faruque; M J Albert; R I Glass
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

3.  VP4 and VP7 genotyping of rotavirus samples recovered from infected children in Ireland over a 3-year period.

Authors:  J O'Mahony; B Foley; S Morgan; J G Morgan; C Hill
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

4.  Serum rotavirus neutralizing-antibody titers compared by plaque reduction and enzyme-linked immunosorbent assay-based neutralization assays.

Authors:  R L Ward; A Z Kapikian; K M Goldberg; D R Knowlton; M W Watson; R Rappaport
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

5.  Severe gastroenteritis associated with G3P[9] rotavirus in Taiwan.

Authors:  K-P Hwang; Y-C Huang; K Bányai; H-S Wu; F-Y Chang; D C-F Yang; C A Hsiung; J-S Lin; B Jiang; J R Gentsch; F-T Wu
Journal:  Infection       Date:  2011-03-22       Impact factor: 3.553

6.  Sequence analysis of human rotavirus strains: comparison of clinical isolates from Northern and Southern Italy.

Authors:  T Grassi; F Bagordo; A Cavallaro; M Guido; C Malaventura; G Gabutti; A De Donno
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-28       Impact factor: 3.267

7.  Serotype specificity of the neutralizing-antibody response induced by the individual surface proteins of rotavirus in natural infections of young children.

Authors:  G Menchaca; L Padilla-Noriega; M Méndez-Toss; J F Contreras; F I Puerto; H Guiscafré; F Mota; I Herrera; R Cedillo; O Muñoz; R Ward; Y Hoshino; S López; C F Arias
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

8.  Rotavirus vaccines in Israel: Uptake and impact.

Authors:  Khitam Muhsen; Daniel Cohen
Journal:  Hum Vaccin Immunother       Date:  2017-03-10       Impact factor: 3.452

9.  Unusual diversity of human rotavirus G and P genotypes in India.

Authors:  M Ramachandran; B K Das; A Vij; R Kumar; S S Bhambal; N Kesari; H Rawat; L Bahl; S Thakur; P A Woods; R I Glass; M K Bhan; J R Gentsch
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

10.  Distribution of rotavirus VP4 genotypes and VP7 serotypes among nonhospitalized and hospitalized patients with gastroenteritis and patients with nosocomially acquired gastroenteritis in Austria.

Authors:  M Frühwirth; S Brösl; H Ellemunter; I Moll-Schüler; A Rohwedder; I Mutz
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.